Sector Chart Compugen Ltd.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-03 pm EDT			5-day change	1st Jan Change
2.19 ^USD	+0.92%		-10.25%	+10.61%

May. 30	Compugen Ltd. to Receive Milestone Payment from Astrazeneca Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig	CI
May. 20	Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes